Hypertension Trial, Recruiting (NCT07027254)

Hypertension Trial, Recruiting NCT07027254 Sponsor: Seoul National University Hospital Condition: Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07027254 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 19 years old or older
You have been diagnosed with a condition called primary aldosteronism (PA), based on specific medical guidelines from 2016
You have already had a CT scan of your adrenal glands
You are willing and able to sign a consent form agreeing to take part in the study

Who may not be able to join:

Women who are pregnant, currently breastfeeding, or who could become pregnant during the study
People who are not willing to have surgery as part of the study
People who are unable to have, or who refuse to have, certain specialised scans (called 68Ga-Pentixafor PET/CT or 11C-Metomidate PET/CT) or a procedure involving sampling blood from veins near the adrenal glands (called adrenal venous sampling), for any reason including health conditions
People who are unwilling to take, or who have had a bad reaction to, a medication called dexamethasone, which is required before one of the scans
People who have previously had open abdominal or back-of-the-abdomen (retroperitoneal) surgery on the same side of the body where the planned adrenal surgery would take place
Anyone the study doctors consider unsuitable for the trial for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07027254

Sponsor: Seoul National University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Hypertension

More information: https://clinicaltrials.gov/study/NCT07027254

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 19 years old or older
You have been diagnosed with a condition called primary aldosteronism (PA), based on specific medical guidelines from 2016
You have already had a CT scan of your adrenal glands
You are willing and able to sign a consent form agreeing to take part in the study

Who may not be able to join:

Women who are pregnant, currently breastfeeding, or who could become pregnant during the study
People who are not willing to have surgery as part of the study
People who are unable to have, or who refuse to have, certain specialised scans (called 68Ga-Pentixafor PET/CT or 11C-Metomidate PET/CT) or a procedure involving sampling blood from veins near the adrenal glands (called adrenal venous sampling), for any reason including health conditions
People who are unwilling to take, or who have had a bad reaction to, a medication called dexamethasone, which is required before one of the scans
People who have previously had open abdominal or back-of-the-abdomen (retroperitoneal) surgery on the same side of the body where the planned adrenal surgery would take place
Anyone the study doctors consider unsuitable for the trial for any other reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Seoul National University Hospital

Registry

ClinicalTrials.gov

Start date

25 June 2025

Est. completion

1 June 2027

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Biochemical remission rate after adrenalectomy (surgery group only)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov